They are more suited for fine-tuning body composition in already-lean individuals
Peptides That May Pair Well With BPC-157 Pairing decisions should always be clinician-led
Lancet 335 (8700), 12331235
However, the majority of recently developed SARMs have non-steroidal structures, which may be based on [22]: Aryl-propionamide (andarine, ostarine, RAD140) Bicyclic hydantoin (BMS-564,929) Quinolinones and tetrahydroquinoline analogs Benizimidazole, imidazolopyrazole, indole, and pyrazoline derivaties Aniline, diaryl aniline, and bezoxazepinones derivatives Regardless of structure, all SARMs work by interacting with the androgen receptors (ARs) in specific tissues, i.e., selectively, rather than activating ARs throughout the body
Several compounds with less theoretical concern about angiogenesis may serve as alternatives